Good Clinical Practice and Its
Principles
Good Clinical Practice (GCP) is a scientific and ethical quality
standard that accounts for the design, conduct, monitoring,
performance, auditing and reporting of clinical trials. Actually, it
provides surety that the results of the clinical trials are accurate, and
the rights and confidentiality of the trial subjects are protected.
Principles of GCP
The unified standard aims at regulating the clinical trials that involve
human subjects. It offers the assurance of the safety of compounds
(that are developed in the clinical trials) and the human right
protection of the participants. Also, the GCP standards define the
role of investigators, sponsors, and associates in the clinical trials.
Here we have listed the main principles of GoodClinical Practice.
 The safety, rights and well-being of the participants should
prevail over the interests of societyand science.
 Each member of the clinical trial staff, i.e. every individual
involved in the trial conducts must be qualified in terms of
education, training and experience.
 Clinical trials must be based on scientific facts and should be
guided and supported by ethical principles.
 Procedures that aim at securing the quality of each aspect of the
trial should be compiled with.
 The available information (whether it is clinical or non-clinical)
on the products/procedures/devices that are being investigated
should be accurate and adequate to support the trail.
 All the clinical trials should be planned and conducted in
accordancewith the Declarationof Helsinki principles.
 A protocol defining the inclusion and exclusion of the participants
in clinical trials, publication policy and monitoring should be
provided.
 Sponsors and investigators should take into consideration all the
related and relevant guidance while commencing and conducting
the clinicaltrials.
 The information about the clinical trials should be recorded and
managed in a way that it can be accurately interpreted, reported
and verified. All this needs to be done while protecting the
confidentiality of the records ofthe participants.
 Before any trial is initiated, the foreseeable risks should be
weighed against the expected benefits for the trial subjects as well
as the present and future patients. Clinical trials should only be
initiated if the expectedbenefits justify the presumed risks.
 The clinical trials should be initiated only if the licensing
authority and the ethics committee agree that the anticipated
benefits justify the expected risks. And the trials should be
continued only if their compliance with this requirement is
monitored on regularbasis.
 Whether it is the medical care given to the trial subjects or the
decisions made on their behalf, both should be the responsibility
of a qualified doctor or dentist who is involved in the trial.
 The rights of the subjects to privacy, data protection, and physical
and mental integrity need to be safeguardedthroughout the trial.
 Provision needs to be made for insurance to cover the liability of
the sponsor and the investigator that may arise in the clinical
trials.
Thus, the main aim of the GCP standards is to assure that the results
of the clinical trials are safe and accurate, and the confidentiality of
the subjects is protected. So, the organizations that conduct the
clinical trials should consider all the above-mentioned principles
while conducting trials.
Contact Us
Address- 300 South StreetASuite 201 Oxnard,
CA, USA 93030
Phone- +1-805-483-1185
Email- info@fomatmedical.com
Website- www.fomatmedical.com

Good clinical practice and its principles

  • 1.
    Good Clinical Practiceand Its Principles Good Clinical Practice (GCP) is a scientific and ethical quality standard that accounts for the design, conduct, monitoring, performance, auditing and reporting of clinical trials. Actually, it provides surety that the results of the clinical trials are accurate, and the rights and confidentiality of the trial subjects are protected. Principles of GCP The unified standard aims at regulating the clinical trials that involve human subjects. It offers the assurance of the safety of compounds (that are developed in the clinical trials) and the human right protection of the participants. Also, the GCP standards define the
  • 2.
    role of investigators,sponsors, and associates in the clinical trials. Here we have listed the main principles of GoodClinical Practice.  The safety, rights and well-being of the participants should prevail over the interests of societyand science.  Each member of the clinical trial staff, i.e. every individual involved in the trial conducts must be qualified in terms of education, training and experience.  Clinical trials must be based on scientific facts and should be guided and supported by ethical principles.  Procedures that aim at securing the quality of each aspect of the trial should be compiled with.  The available information (whether it is clinical or non-clinical) on the products/procedures/devices that are being investigated should be accurate and adequate to support the trail.
  • 3.
     All theclinical trials should be planned and conducted in accordancewith the Declarationof Helsinki principles.  A protocol defining the inclusion and exclusion of the participants in clinical trials, publication policy and monitoring should be provided.  Sponsors and investigators should take into consideration all the related and relevant guidance while commencing and conducting the clinicaltrials.  The information about the clinical trials should be recorded and managed in a way that it can be accurately interpreted, reported and verified. All this needs to be done while protecting the confidentiality of the records ofthe participants.  Before any trial is initiated, the foreseeable risks should be weighed against the expected benefits for the trial subjects as well as the present and future patients. Clinical trials should only be initiated if the expectedbenefits justify the presumed risks.  The clinical trials should be initiated only if the licensing authority and the ethics committee agree that the anticipated benefits justify the expected risks. And the trials should be continued only if their compliance with this requirement is monitored on regularbasis.
  • 4.
     Whether itis the medical care given to the trial subjects or the decisions made on their behalf, both should be the responsibility of a qualified doctor or dentist who is involved in the trial.  The rights of the subjects to privacy, data protection, and physical and mental integrity need to be safeguardedthroughout the trial.  Provision needs to be made for insurance to cover the liability of the sponsor and the investigator that may arise in the clinical trials. Thus, the main aim of the GCP standards is to assure that the results of the clinical trials are safe and accurate, and the confidentiality of the subjects is protected. So, the organizations that conduct the clinical trials should consider all the above-mentioned principles while conducting trials.
  • 5.
    Contact Us Address- 300South StreetASuite 201 Oxnard, CA, USA 93030 Phone- +1-805-483-1185 Email- info@fomatmedical.com Website- www.fomatmedical.com